OS Therapies Inc SEC filings OSTX
OS Therapies Inc has 243 filings in SEC EDGAR's recent list, going back to Dec 5, 2019. Its latest annual report, Form ARS, was filed on Jul 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (material agreement, unregistered share sale, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Sep 21, 2026 | — |
| 424B7 | Prospectus supplement | Sep 10, 2026 | — |
| 424B5 | Prospectus supplement | Aug 21, 2026 | — |
| 424B5 | Prospectus supplement | Aug 6, 2026 | — |
| 424B5 | Prospectus supplement | Apr 2, 2026 | — |
| 424B7 | Prospectus supplement | Mar 31, 2026 | — |
| S-8 | Employee stock plan registration | Oct 31, 2025 | — |
| 424B7 | Prospectus supplement | Sep 30, 2025 | — |
| 424B5 | Prospectus supplement | Aug 25, 2025 | — |
| 424B3 | Prospectus | Aug 25, 2025 | — |
| S-3 | Shelf registration | Aug 8, 2025 | — |
| S-1 | Registration statement | Aug 4, 2025 | — |
| S-1 | Registration statement | May 23, 2025 | — |
| POS AM | Post-effective amendment | Apr 21, 2025 | — |
| POS AM | Registration statement | Apr 21, 2025 | — |
| S-1 | Registration statement | Jan 31, 2025 | — |
| S-8 | Employee stock plan registration | Jan 13, 2025 | — |
| S-1/A | Amended registration statement | Jan 3, 2025 | — |
| S-1/A | Amended registration statement | Nov 27, 2024 | — |
| S-1 | Registration statement | Nov 12, 2024 | — |
| 424B4 | Prospectus | Aug 1, 2024 | — |
| S-1/A | Amended registration statement | Jun 13, 2024 | — |
| S-1/A | Amended registration statement | Jun 7, 2024 | — |
| S-1 | Registration statement | May 30, 2024 | — |
| POS AM | Post-effective amendment | May 13, 2024 | — |
| S-1/A | Amended registration statement | Jan 25, 2024 | — |
| S-1/A | Amended registration statement | Dec 22, 2023 | — |
| S-1/A | Amended registration statement | May 22, 2023 | — |
| S-1/A | Amended registration statement | Apr 24, 2023 | — |
| S-1/A | Amended registration statement | Apr 13, 2023 | — |
| S-1 | Registration statement | Mar 31, 2023 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OSTX (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rockville, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1795091
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.